Mark Schroeder

15PUBLICATIONS
72CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical mycologyHaematologyImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Apr 14, 2026
Safety and efficacy of ciltacabtagene autoleucel for relapsed/refractory multiple myeloma: a CIBMTR study.

Doris K Hansen, Danai Dima, Hira Mian

|Mar 19, 2025
Low rates of chronic graft-versus-host disease with ruxolitinib maintenance following allogeneic HCT.

Zachariah DeFilipp, Haesook T Kim, Laura W Knight

|Mar 12, 2025
Memory-like NK cell differentiation, inhibitory NKG2A blockade, and improved recognition via antibody or CAR engineering combine to enhance NK cell attack against multiple myeloma.

Alice Y Zhou, Nancy D Marin, Sadia Afrin

|Nov 01, 2024
LINC01432 binds to CELF2 in newly diagnosed multiple myeloma promoting short progression-free survival to standard therapy.

Richa Mishra, Prasanth Thunuguntla, Alani Perkin

|May 29, 2023
Acute Graft-versus-Host Disease: An Update on New Treatment Options.

Dilan A Patel, Mallory Crain, Iskra Pusic

|Apr 17, 2023
Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trial.

Zachary D Crees, Michael P Rettig, Reyka G Jayasinghe

Pageof 3

Frequent Collaborators

3 joint publications

Keith Stockerl-Goldstein

2 joint publications

Taiga Nishihori

2 joint publications

Reyka Jayasinghe

2 joint publications

Celia C Cubitt